Samsung Biologics Co.,Ltd.
207940
Rankning i aktier
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Aktiekurs
$1,028.49
Marknadsvärde
$47.88B
Förändring (1 dag)
-3.67%
Förändring (1 år)
-18.37%
Land
KR
Handel Samsung Biologics Co.,Ltd. (207940)
Kategori
Healthcare
Historik för aktiesplit för Samsung Biologics Co.,Ltd. (207940)
Aktien Samsung Biologics Co.,Ltd. (symbol: 207940) har genomgått totalt 1 aktiesplitar.
Den senaste spliten skedde den Oct 30, 2025.
En 207940-aktie köpt före Oct 30, 2025 motsvarar nu 0.650391 207940-aktier.
Den senaste spliten skedde den Oct 30, 2025.
En 207940-aktie köpt före Oct 30, 2025 motsvarar nu 0.650391 207940-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| 2025-10-30 | 650391:1000000 | x0.650391 | x0.650391 |
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
